Stockreport

LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical Conferences

LENZ Therapeutics, Inc.  (LENZ) 
PDF SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focuse [Read more]